FDLI Orphan Drug Forum: Regulatory, Compliance, and Business Issues in Rare Diseases

Arnold & Porter is proud to be sponsoring and presenting at the Food & Drug Law Institute’s (FDLI) Orphan Drug Forum, a one-day, in-person conference in Boston designed for the biotechnology community. The forum examines the legal, regulatory, policy, compliance, and business issues in the U.S. and Europe that are unique to rare disease therapies across the product lifecycle, from early clinical research through commercialization.

The program is relevant to in-house counsel, compliance leaders, and business executives at companies with marketed or pipeline orphan products, as well as manufacturers considering entering the space.